blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1660519

EP1660519 - Conjugates comprising 2-[18F]fluoro-2-deoxy-D-glucose and a peptide molecule [Right-click to bookmark this link]
Former [2006/22]FLUORINATED CARBOHYDRATE CONJUGATES
[2013/42]
StatusNo opposition filed within time limit
Status updated on  20.03.2015
Database last updated on 05.07.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Immunomedics, Inc.
300 American Road
Morris Plains, NJ 07950 / US
[2014/20]
Former [2006/22]For all designated states
Immunomedics, Inc.
300 American Road Morris Plains
New Jersey 07950 / US
Inventor(s)01 / MCBRIDE, William J.
c/o Immunomedics, Inc.
300 American Road
Morris Plains, NJ 07950 / US
02 / GOLDENBERG, David M.
c/o Immunomedics, Inc.
300 American Road
Morris Plains, NJ 07950 / US
 [2014/02]
Former [2006/22]01 / MCBRIDE, William J.
116 Glover Street
Boonton, NJ 07005 / US
02 / GOLDENBERG, David M.
1 Charolais Farm Road
Mendham, NJ 07945 / US
Representative(s)Bohmann, Armin K., et al
Bohmann
Anwaltssozietät
Nymphenburger Strasse 1
80335 München / DE
[N/P]
Former [2014/20]Bohmann, Armin K., et al
bohmann Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Former [2006/22]Bohmann, Armin K., et al
Bohmann & Loosen, Anwaltssozietät, Sonnenstrasse 8
80331 München / DE
Application number, filing date04821595.829.07.2004
[2006/22]
WO2004US24237
Priority number, dateUS20030490884P29.07.2003         Original published format: US 490884 P
[2006/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005086612
Date:22.09.2005
Language:EN
[2005/38]
Type: A2 Application without search report 
No.:EP1660519
Date:31.05.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 22.09.2005 takes the place of the publication of the European patent application.
[2006/22]
Type: B1 Patent specification 
No.:EP1660519
Date:14.05.2014
Language:EN
[2014/20]
Search report(s)International search report - published on:US06.12.2007
(Supplementary) European search report - dispatched on:EP31.08.2010
ClassificationIPC:A61K51/04, A61K51/08, C07H5/02, // A61K101/02
[2013/42]
CPC:
C07H3/00 (EP,US); A61K47/64 (EP,US); A61K47/6879 (EP,US);
A61K47/6897 (EP,US); A61K49/0433 (EP,US); A61K49/085 (EP,US);
A61K49/14 (EP,US); A61K51/0491 (EP,US); A61K51/088 (EP,US);
A61P35/00 (EP); B82Y5/00 (EP,US); C07K16/3007 (EP,US);
C07K16/44 (EP,US); C07K2317/55 (EP,US) (-)
Former IPC [2010/39]A61K51/04, A61K51/08, A61K51/10, C07H5/02, A61K49/10, A61K49/14, A61K49/16, A61K47/48, A61K49/08, // A61K101/02
Former IPC [2008/09]C07H5/02, C07H1/00
Former IPC [2006/22]C07K1/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/22]
TitleGerman:Konjugate von 2-[18F]Fluor-2-desoxy-D-glucose und einem Peptid-Molekül[2013/42]
English:Conjugates comprising 2-[18F]fluoro-2-deoxy-D-glucose and a peptide molecule[2013/42]
French:Conjugués comprenant le 2-[18F]-fluoro-2-désoxy-D-glucose et une molécule peptidique[2013/42]
Former [2006/22]KONJUGATE FLUORIERTER KOHLENHYDRATE
Former [2006/22]FLUORINATED CARBOHYDRATE CONJUGATES
Former [2006/22]CONJUGUES GLUCIDIQUES FLUORES
Entry into regional phase25.01.2006National basic fee paid 
25.01.2006Search fee paid 
25.01.2006Designation fee(s) paid 
25.01.2006Examination fee paid 
Examination procedure25.01.2006Examination requested  [2006/22]
14.06.2012Despatch of a communication from the examining division (Time limit: M06)
02.01.2013Reply to a communication from the examining division
07.02.2013Despatch of a communication from the examining division (Time limit: M06)
19.08.2013Reply to a communication from the examining division
02.10.2013Communication of intention to grant the patent
06.02.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
06.02.2014Fee for grant paid
06.02.2014Fee for publishing/printing paid
21.02.2014Communication of intention to grant the patent
24.03.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.06.2012
Opposition(s)17.02.2015No opposition filed within time limit [2015/17]
Fees paidRenewal fee
25.01.2006Renewal fee patent year 03
13.07.2007Renewal fee patent year 04
15.07.2008Renewal fee patent year 05
20.07.2009Renewal fee patent year 06
27.07.2010Renewal fee patent year 07
25.07.2011Renewal fee patent year 08
23.07.2012Renewal fee patent year 09
22.07.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.07.2004
AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
TR14.05.2014
IE29.07.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
[2016/33]
Former [2016/32]HU29.07.2004
AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE29.07.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2016/25]AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE29.07.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2016/21]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE29.07.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/37]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE29.07.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/36]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/22]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
IT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/20]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
LU29.07.2014
CH31.07.2014
LI31.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/13]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
LU29.07.2014
GR15.08.2014
PT15.09.2014
Former [2015/12]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
PT15.09.2014
Former [2015/11]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
PT15.09.2014
Former [2015/10]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
PT15.09.2014
Former [2015/08]AT14.05.2014
BE14.05.2014
CY14.05.2014
DK14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
PT15.09.2014
Former [2015/02]AT14.05.2014
CY14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
PT15.09.2014
Former [2014/51]AT14.05.2014
CY14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
Former [2014/50]CY14.05.2014
ES14.05.2014
FI14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
Former [2014/49]CY14.05.2014
FI14.05.2014
Former [2014/47]CY14.05.2014
Documents cited:Search[XI]EP1034797  (FORSCHUNGSZENTRUM JUELICH GMBH [DE]) [X] 1,2,4,5,37,38,45,46,111-115,117 * paragraph [0016] * * figures 1,3 * * claim - * [I] 32-36,39-43;
 [A]WO03059397  (IMMUNOMEDICS INC [US], et al) [A] 1-22,27-43,45-59,69-115,117-122,136 * example 2 * * claim - *;
 [XPI]WO03086475  (A & D BIOSCIENCE INC [US], et al) [XP] 1,2,4,5,37-39,111-115,117 * paragraphs [0036] , [0037] * * page 12, last compound * [I] 32-36,40-43;
 [E]WO2005028490  (THESEUS IMAGING CORP [US], et al) [E] 1-5,27,32,33,35-38,45-47,111-115,117 * page 3, line 32 - page 4, line 20 * * page 12, lines 1-5 * * page 23, line 1 - page 24, line 19 * * example 1 ** claim - *;
 [XI]  - HAUBNER R ET AL, "Noninvasive imaging of [alpha]v[beta]3 integrin expression using <18>F-labeled RGD-containing glycopeptide and positron emission tomography", CANCER RESEARCH 20010301 US, (20010301), vol. 61, no. 5, ISSN 0008-5472, pages 1781 - 1785, XP002596911 [X] 1,4,5,37,38,111-115,117 * abstract * * page 1781, section "Preparation of [18F]Galacto-RGD" * * page 1782; figure 1 * * page 1784, column right * [I] 32-36,39-43
 [AD]  - PATT M ET AL, "Adduct of 2-[<18>F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization", APPLIED RADIATION AND ISOTOPES, ELSEVIER, OXFORD, GB LNKD- DOI:10.1016/S0969-8043(02)00186-0, (20021101), vol. 57, no. 5, ISSN 0969-8043, pages 705 - 712, XP004381725 [AD] 1-22,27-43,45-59,69-115,117-122,136 * abstract * * page 710; figure 5 *

DOI:   http://dx.doi.org/10.1016/S0969-8043(02)00186-0
 [A]  - SORGER D ET AL, "[<18>F]Fluoroazomycinarabinofuranoside (<18>FAZA) and [<18>F]Fluoromisonidazole (<18>FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors", NUCLEAR MEDICINE AND BIOLOGY, ELSEVIER, NY, US LNKD- DOI:10.1016/S0969-8051(02)00442-0, (20030401), vol. 30, no. 3, ISSN 0969-8051, pages 317 - 326, XP004425105 [A] 1-22,27-43,45-59,69-115,117-122,136 * abstract *

DOI:   http://dx.doi.org/10.1016/S0969-8051(02)00442-0
 [A]  - BARTHEL H ET AL, "3'-Deoxy-3'-[<18>f]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography", CANCER RESEARCH 20030701 US, (20030701), vol. 63, no. 13, ISSN 0008-5472, pages 3791 - 3798, XP002596912 [A] 1-22,27-43,45-59,69-115,117-122,136 * abstract *
International search[A]US5057301  (WILBUR DANIEL S [US])
by applicantUS5633425
 US5827690
    - KANEKO ET AL., J. BIOCONJUGATE CHEM., (1991), vol. 2, pages 133 - 141
    - YU ET AL., NAT. IMMUNOL., (2000), vol. 1, pages 252 - 256
    - MENDEZ ET AL., NATURE GENETICS, (1997), vol. 15, pages 146 - 156
    - TOMIZUKA ET AL., NATURE GENETICS, (1997), vol. 16, page 133
    - PRODUCTION, ENGINEERING AND CLINICAL APPLICATION, CAMBRIDGE UNIVERSITY PRESS, (1995), pages 166 - 179
    - "Genetic Manipulation and Expression of Antibodies", WARD ET AL., MONOCLONAL ANTIBODIES: PRINCIPLES AND APPLICATIONS, WILEY-LISS, INC., (1995), pages 137 - 185
    - COLMAN, A., BIOCHEM. SOC. SYMP., (1998), vol. 63, pages 141 - 147
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.